- Home
- CTMX vs SD Comparison
CTMX vs SD Comparison
Compare CTMX & SD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- SD
- Stock Information
- Founded
- CTMX 2008
- SD 2006
- Country
- CTMX United States
- SD United States
- Employees
- CTMX N/A
- SD N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- SD Oil & Gas Production
- Sector
- CTMX Health Care
- SD Energy
- Exchange
- CTMX Nasdaq
- SD Nasdaq
- Market Cap
- CTMX 349.6M
- SD 380.4M
- IPO Year
- CTMX 2015
- SD 2007
- Fundamental
- Price
- CTMX $2.13
- SD $11.44
- Analyst Decision
- CTMX Strong Buy
- SD
- Analyst Count
- CTMX 3
- SD 0
- Target Price
- CTMX $5.67
- SD N/A
- AVG Volume (30 Days)
- CTMX 4.1M
- SD 300.2K
- Earning Date
- CTMX 11-06-2025
- SD 11-05-2025
- Dividend Yield
- CTMX N/A
- SD 4.20%
- EPS Growth
- CTMX 263.20
- SD 86.17
- EPS
- CTMX 0.49
- SD 2.03
- Revenue
- CTMX $141,100,000.00
- SD $146,165,000.00
- Revenue This Year
- CTMX N/A
- SD $30.71
- Revenue Next Year
- CTMX N/A
- SD $10.06
- P/E Ratio
- CTMX $4.66
- SD $5.64
- Revenue Growth
- CTMX 18.01
- SD 13.89
- 52 Week Low
- CTMX $0.40
- SD $8.81
- 52 Week High
- CTMX $3.10
- SD $13.19
- Technical
- Relative Strength Index (RSI)
- CTMX 49.61
- SD 52.71
- Support Level
- CTMX $2.02
- SD $11.47
- Resistance Level
- CTMX $2.17
- SD $12.16
- Average True Range (ATR)
- CTMX 0.14
- SD 0.31
- MACD
- CTMX 0.03
- SD -0.02
- Stochastic Oscillator
- CTMX 55.42
- SD 53.07
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About SD SandRidge Energy Inc.
SandRidge Energy Inc is a United States-based oil and natural gas company. It is engaged in the exploration, development, and production of crude oil, natural gas, and Natural gas liquids. Business activities of the group include Exploration and Production, Drilling and Oil Field Services, and Midstream Gas Services. Its primary areas of operation are the Mid-Continent in Oklahoma and Kansas.